This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence. Issue 6 (June 2023)
Record Type:
Journal Article
Title:
Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence. Issue 6 (June 2023)
Main Title:
Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence